CYH:NYE-Community Health Systems, Inc (USD)

COMMON STOCK | Medical Care Facilities | NYE

Last Closing Price

USD 3.25

Change

-0.10 (-2.99)%

Market Cap

USD 0.40B

Volume

1.55M

Average Target Price

USD 6.17 (+89.74%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Community Health Systems, Inc., through its subsidiaries, owns, leases, and operates general acute care hospitals in the United States. The company offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. It also provides outpatient services at urgent care centers, occupational medicine clinics, imaging centers, cancer centers, and ambulatory surgery centers. As of December 31, 2019, it owned or leased 102 hospitals, including 100 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals with an aggregate of 16,240 licensed beds. Community Health Systems, Inc. was founded in 1985 and is headquartered in Franklin, Tennessee.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-06-03 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HCA HCA Healthcare, Inc

-1.08 (-0.99%)

USD36.81B 12.38 8.01
FMS Fresenius Medical Care AG & Co..

+0.01 (+0.02%)

USD25.39B 19.04 10.00
DVA DaVita Inc

-1.14 (-1.41%)

USD9.79B 14.23 8.50
UHS Universal Health Services, Inc

+0.40 (+0.38%)

USD8.83B 12.75 8.06
CHE Chemed Corporation

+2.91 (+0.62%)

USD7.40B 34.47 23.76
EHC Encompass Health Corporation

-0.17 (-0.23%)

USD7.34B 21.47 11.68
THC Tenet Healthcare Corporation

N/A

USD2.32B 22.20 8.05
SEM Select Medical Holdings Corpor..

+0.64 (+3.91%)

USD2.16B 13.16 9.64
AMN AMN Healthcare Services, Inc

+0.64 (+1.44%)

USD2.09B 23.41 13.85
MD MEDNAX, Inc

+0.43 (+2.61%)

USD1.41B 9.15 N/A

ETFs Containing CYH

Symbol Name Weight Mer Price(Change) Market Cap
RWJ Invesco S&P SmallCap 600 .. 1.90 % 0.39 %

+1.64 (+2.96%)

USD0.21B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.07% 95% A 92% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.07% 95% A 92% A-
Trailing 12 Months  
Capital Gain 10.54% 71% C- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.54% 71% C- 78% C+
Trailing 5 Years  
Capital Gain -94.00% 13% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -94.00% 13% F 2% F
Average Annual (5 Year Horizon)  
Capital Gain -35.50% 6% F N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -35.50% 6% F N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 29.22% 28% F 23% F
Risk Adjusted Return -121.48% 17% F 1% F
Market Capitalization 0.40B 33% F 44% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 1.04 81% B- 78% C+
EV/EBITDA 12.32 47% F 40% F
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital 6.20% 29% F 51% F
Return on Assets 3.27% 43% F 61% D-
Debt to Equity Ratio -603.47% 85% B 98% A+
Technical Ratios  
Short Ratio 7.05 10% F 9% F
Short Percent 22.27% 5% F 28% F
Beta 1.60 24% F 21% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector